Importantly, the upregulation of Bcl-6 to T-bet at the late stage, coinciding with the time when the anti-viral response waned but anti-tumor responses persisted, allowed for the expansion of a memory CD4+ T-cell subset that was responsible for long-lasting protective anti-tumor immunity. The gene discussed is CD4; the disease is neoplasm.